105 related articles for article (PubMed ID: 2805539)
1. Technetium-99m labeled monoclonal antibodies in the detection of metastatic melanoma.
Serafini AN; Kotler J; Feun L; Dewanjee M; Robinson D; Salk D; Sfakianakis G; Abrams P; Savaraj N; Goodwin D
Clin Nucl Med; 1989 Aug; 14(8):580-7. PubMed ID: 2805539
[TBL] [Abstract][Full Text] [Related]
2. Successful imaging of malignant melanoma with technetium-99m-labeled monoclonal antibodies.
Eary JF; Schroff RW; Abrams PG; Fritzberg AR; Morgan AC; Kasina S; Reno JM; Srinivasan A; Woodhouse CS; Wilbur DS
J Nucl Med; 1989 Jan; 30(1):25-32. PubMed ID: 2642954
[TBL] [Abstract][Full Text] [Related]
3. A technetium-labeled monoclonal antibody for imaging metastatic melanoma.
Frytak S; Creagan ET; Brown ML; Salk D; Nelp W
Am J Clin Oncol; 1991 Apr; 14(2):156-61. PubMed ID: 2028923
[TBL] [Abstract][Full Text] [Related]
4. [Immunoscintigraphy with a technetium 99m-labeled monoclonal antibody in patients with melanoma].
Dudczak R; Kletter K; Bailer H; Kokoschka E; Pohl-Markl H
Wien Klin Wochenschr; 1987 Apr; 99(7):232-9. PubMed ID: 3590802
[TBL] [Abstract][Full Text] [Related]
5. Multicenter study of immunoscintigraphy with radiolabeled monoclonal antibodies in patients with melanoma.
Siccardi AG; Buraggi GL; Callegaro L; Mariani G; Natali PG; Abbati A; Bestagno M; Caputo V; Mansi L; Masi R
Cancer Res; 1986 Sep; 46(9):4817-22. PubMed ID: 3731128
[TBL] [Abstract][Full Text] [Related]
6. Radioimaging of melanoma using 99mTc-labeled Fab fragment reactive with a high molecular weight melanoma antigen.
Lamki LM; Zukiwski AA; Shanken LJ; Legha SS; Benjamin RS; Plager CE; Salk DF; Schroff RW; Murray JL
Cancer Res; 1990 Feb; 50(3 Suppl):904s-908s. PubMed ID: 2297740
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody imaging of human melanoma. Radioimmunodetection by subcutaneous or systemic injection.
Lotze MT; Carrasquillo JA; Weinstein JN; Bryant GJ; Perentesis P; Reynolds JC; Matis LA; Eger RR; Keenan AM; Hellström I
Ann Surg; 1986 Sep; 204(3):223-35. PubMed ID: 3753057
[TBL] [Abstract][Full Text] [Related]
8. Anti-melanoma antibodies bind preferentially to diploid metastases in immunoscintigraphy.
Pyrhönen S; Liewendahl K; Muhonen T; Laasonen A; Asko-Seljavaara S; Lindroth L; Franssila KO; Virkkunen P; Brownell AL
Nucl Med Commun; 1990 Sep; 11(9):597-605. PubMed ID: 2234695
[TBL] [Abstract][Full Text] [Related]
9. [Immunoscintigraphy with 99mTc marked melanoma antibody in patients with malignant melanoma].
Rentsch M; Cerny T; Richner J; Brunner KW; Rösler H; Nachbur B
Helv Chir Acta; 1989 Jun; 56(1-2):11-3. PubMed ID: 2777587
[TBL] [Abstract][Full Text] [Related]
10. Clinical experience with Tc-99m labeled (N2S2) anti-melanoma antibody fragments and single photon emission computed tomography.
Wahl RL; Swanson NA; Johnson JW; Natale R; Petry NA; Mallette S; Kasina S; Reno J; Sullivan K; Abrams P
Am J Physiol Imaging; 1992; 7(2):48-58. PubMed ID: 1419120
[TBL] [Abstract][Full Text] [Related]
11. Radioimmunoscintigraphy in patients with early stage cutaneous malignant melanoma.
Blend MJ; Hyun H; Patel B; Sullivan K; Salk D
J Nucl Med; 1996 Feb; 37(2):252-7. PubMed ID: 8667055
[TBL] [Abstract][Full Text] [Related]
12. Role of technetium 99m-labeled monoclonal antibody in the management of melanoma patients.
Blend MJ; Ronan SG; Salk DJ; Gupta TK
J Clin Oncol; 1992 Aug; 10(8):1330-7. PubMed ID: 1634923
[TBL] [Abstract][Full Text] [Related]
13. Localization of malignant melanoma using monoclonal antibodies.
Wasselle J; Becker J; Cruse W; Espinosa C; Cox C; Reintgen D
Arch Surg; 1991 Apr; 126(4):481-4. PubMed ID: 2009063
[TBL] [Abstract][Full Text] [Related]
14. Staging of regional lymph nodes in melanoma patients by means of 99mTc-MIBI scintigraphy.
Alonso O; Martínez M; Delgado L; De León A; De Boni D; Lago G; Garcés M; Fontes F; Espasandín J; Priario J
J Nucl Med; 2003 Oct; 44(10):1561-5. PubMed ID: 14530467
[TBL] [Abstract][Full Text] [Related]
15. The diagnostic role of 99mTc-dual receptor targeted probe and targeted peptide bombesin (RGD-BBN) SPET/CT in the detection of malignant and benign breast tumors and axillary lymph nodes compared to ultrasound.
Ji T; Sun Y; Chen B; Ji B; Gao S; Ma Q; Cheng G; Zhang H
Hell J Nucl Med; 2015; 18(2):108-13. PubMed ID: 26187209
[TBL] [Abstract][Full Text] [Related]
16. Immunoscintigraphy with 99mTc labelled F(ab')2 fragments of an anti melanoma monoclonal antibody (225.28S) in patients with metastatic malignant melanoma.
Cerny T; Owens SE; Mackenzie SA; Nuttall PM; Gosh AK; Smith DB; Thatcher N
Eur J Nucl Med; 1987; 13(3):130-3. PubMed ID: 3622556
[TBL] [Abstract][Full Text] [Related]
17. [Radioimmunoscintigraphy with a 99mTc-labeled F(ab')2 fragment of a monoclonal antibody (HMW-MAA 225.28S) in 71 patients with malignant melanoma].
Rentsch M; Cerny T; Geiger L; Gerber H; Brunner KW; Rösler H; Nachbur B
Schweiz Med Wochenschr; 1989 Oct; 119(40):1382-5. PubMed ID: 2552577
[TBL] [Abstract][Full Text] [Related]
18. Improved immunoscintigraphy by subcutaneous injection of 99mTc or 111In labelled F(ab')2 fragments of an anti-melanoma monoclonal antibody.
Paganelli G; Riva P; Moscatelli G; Stacchiotti A; Agostini M; Landi G; Tison V; Pancea P; Siccardi AG
Int J Rad Appl Instrum B; 1986; 13(4):423-8. PubMed ID: 3793497
[TBL] [Abstract][Full Text] [Related]
19. Anti-melanoma monoclonal antibody 225.28S immunoscintigraphy in metastatic melanoma.
Böni R; Huch Böni RA; Steinert H; Dummer R; Burg G; von Schulthess GK
Dermatology; 1995; 191(2):119-23. PubMed ID: 8520057
[TBL] [Abstract][Full Text] [Related]
20. European multicentre study on melanoma immunoscintigraphy by means of 99mTc-labelled monoclonal antibody fragments. The European Multicentre Study Group.
Siccardi AG; Buraggi GL; Natali PG; Scassellati GA; Viale G; Ferrone S
Eur J Nucl Med; 1990; 16(4-6):317-23. PubMed ID: 2161772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
